The relationship between urinary renin-angiotensin system markers, renal function, and blood pressure in adolescents with type 1 diabetes

American Journal of Physiology - Renal Physiology

Volumn 312, Issue 2, 2017, Pages F335-F342

  Burns, Kevin D ^a   Lytvyn, Yuliya ^b,c   Mahmud, Farid H ^d   Daneman, Denis ^d   Deda, Livia ^d   Dunger, David B ^e   Deanfield, John ^f   Neil Dalton, R ^g   Elia, Yesmino ^d   Har, Ronnie ^c   Van, Julie A D ^c   Bradley, Timothy J ^d   Slorach, Cameron ^d   Hui, Wei ^d   Xiao, Fengxia ^a   Zimpelmann, Joseph ^a   Mertens, Luc ^d   Moineddin, Rahim ^h   Reich, Heather N ^c   Sochett, Etienne ^d   Scholey, James W ^c   Cherney, David Z I ^c   more..

^a OTTAWA HOSPITAL RESEARCH INSTITUTE   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c UNIVERSITY HEALTH NETWORK   (Canada)

^d HOSPITAL FOR SICK CHILDREN   (Canada)

^e UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^f UNIVERSITY COLLEGE HOSPITAL   (United Kingdom)

^g ST THOMAS HOSPITAL   (United Kingdom)

^h UNIVERSITY OF TORONTO   (Canada)

Author keywords

ACE; ACE2; Albumin to creatinine ratio; Hyperglycemia; Type 1 diabetes

Indexed keywords

ALBUMIN; ANGIOTENSINOGEN; CREATININE; DIPEPTIDYL CARBOXYPEPTIDASE; HEMOGLOBIN A1C; MARKER; BIOLOGICAL MARKER;

ADOLESCENT; ALBUMINURIA; ARTICLE; BLOOD PRESSURE; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; ENZYME ACTIVITY; ESTIMATED GLOMERULAR FILTRATION RATE; FEMALE; HUMAN; HYPERGLYCEMIA; INSULIN DEPENDENT DIABETES MELLITUS; KIDNEY FUNCTION; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; OBSERVATIONAL STUDY; PRIORITY JOURNAL; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; URINARY EXCRETION; GLOMERULUS FILTRATION RATE; KIDNEY; METABOLISM; PATHOPHYSIOLOGY; PHYSIOLOGY; URINE;

ADOLESCENT; ALBUMINURIA; ANGIOTENSINOGEN; BIOMARKERS; BLOOD PRESSURE; CREATININE; DIABETES MELLITUS, TYPE 1; FEMALE; GLOMERULAR FILTRATION RATE; HUMANS; KIDNEY; MALE; PEPTIDYL-DIPEPTIDASE A; RENIN-ANGIOTENSIN SYSTEM;

EID: 85012088509     PISSN: 1931857X     EISSN: 15221466     Source Type: Journal    
DOI: 10.1152/ajprenal.00438.2016     Document Type: Article

References (42)

1. Adolescent type 1 Diabetes cardio-renal Intervention Trial Research Group. Adolescent type 1 Diabetes Cardio-renal Intervention Trial (AdDIT). BMC Pediatr 9: 79, 2009. doi:10.1186/1471-2431-9-79.
2. Benter IF, Yousif MH, Cojocel C, Al-Maghrebi M, Diz DI. Angiotensin-( 1-7) prevents diabetes-induced cardiovascular dysfunction. Am J Physiol Heart Circ Physiol 292: H666-H672, 2007. doi:10.1152/ajpheart.00372.2006.
3. Bernardi S, Burns WC, Toffoli B, Pickering R, Sakoda M, Tsorotes D, Grixti E, Velkoska E, Burrell LM, Johnston C, Thomas MC, Fabris B, Tikellis C. Angiotensin-converting enzyme 2 regulates renal atrial natriuretic peptide through angiotensin-(1-7). Clin Sci (Lond) 123: 29-37, 2012. doi:10.1042/CS20110403.
4. Carey RM, Siragy HM. The intrarenal renin-angiotensin system and diabetic nephropathy. Trends Endocrinol Metab 14: 274-281, 2003. doi:10.1016/S1043-2760(03)00111-5.
5. Cherney DZ, Perkins BA, Soleymanlou N, Xiao F, Zimpelmann J, Woerle HJ, Johansen OE, Broedl UC, von Eynatten M, Burns KD. Sodium glucose cotransport-2 inhibition and intrarenal RAS activity in people with type 1 diabetes. Kidney Int 86: 1057-1058, 2014. doi:10.1038/ki.2014.246.
6. Cherney DZ, Xiao F, Zimpelmann J, Har RL, Lai V, Scholey JW, Reich HN, Burns KD. Urinary ACE2 in healthy adults and patients with uncomplicated type 1 diabetes. Can J Physiol Pharmacol 92: 703-706, 2014. doi:10.1139/cjpp-2014-0065.
7. Epstein MP, Lin X, Boehnke M. A tobit variance-component method for linkage analysis of censored trait data. Am J Hum Genet 72: 611-620, 2003. doi:10.1086/367924.
8. Har RL, Reich HN, Scholey JW, Daneman D, Dunger DB, Moineddin R, Dalton RN, Motran L, Elia Y, Deda L, Ostrovsky M, Sochett EB, Mahmud FH, Cherney DZ. The urinary cytokine/chemokine signature of renal hyperfiltration in adolescents with type 1 diabetes. PLoS One 9: e111131, 2014. doi:10.1371/journal.pone.0111131.
9. Hsieh TJ, Fustier P, Wei CC, Zhang SL, Filep JG, Tang SS, Ingelfinger JR, Fantus IG, Hamet P, Chan JS. Reactive oxygen species blockade and action of insulin on expression of angiotensinogen gene in proximal tubular cells. J Endocrinol 183: 535-550, 2004. doi:10.1677/joe.1.05871.
10. Hsieh TJ, Fustier P, Zhang SL, Filep JG, Tang SS, Ingelfinger JR, Fantus IG, Hamet P, Chan JS. High glucose stimulates angiotensinogen gene expression and cell hypertrophy via activation of the hexosamine biosynthesis pathway in rat kidney proximal tubular cells. Endocrinology 144: 4338-4349, 2003. doi:10.1210/en.2003-0220.
11. Hsieh TJ, Zhang SL, Filep JG, Tang SS, Ingelfinger JR, Chan JS. High glucose stimulates angiotensinogen gene expression via reactive oxygen species generation in rat kidney proximal tubular cells. Endocrinology 143: 2975-2985, 2002. doi:10.1210/endo.143.8.8931.
12. Ichihara A, Hayashi M, Kaneshiro Y, Suzuki F, Nakagawa T, Tada Y, Koura Y, Nishiyama A, Okada H, Uddin MN, Nabi AH, Ishida Y, Inagami T, Saruta T. Inhibition of diabetic nephropathy by a decoy peptide corresponding to the "handle" region for nonproteolytic activation of prorenin. J Clin Invest 114: 1128-1135, 2004. doi:10.1172/JCI21398.
13. Marcovecchio ML, Woodside J, Jones T, Daneman D, Neil A, Prevost T, Dalton RN, Deanfield J, Dunger DB; AdDIT Investigators. Adolescent Type 1 Diabetes Cardio-Renal Intervention Trial (AdDIT): urinary screening and baseline biochemical and cardiovascular assessments. Diabetes Care 37: 805-813, 2014. doi:10.2337/dc13-1634.
14. Mizuiri S, Aoki T, Hemmi H, Arita M, Sakai K, Aikawa A. Urinary angiotensin-converting enzyme 2 in patients with CKD. Nephrology (Carlton) 16: 567-572, 2011. doi:10.1111/j.1440-1797.2011.01467.x.
15. Mizuiri S, Hemmi H, Arita M, Ohashi Y, Tanaka Y, Miyagi M, Sakai K, Ishikawa Y, Shibuya K, Hase H, Aikawa A. Expression of ACE and ACE2 in individuals with diabetic kidney disease and healthy controls. Am J Kidney Dis 51: 613-623, 2008. doi:10.1053/j.ajkd.2007.11.022.
16. Nadarajah R, Milagres R, Dilauro M, Gutsol A, Xiao F, Zimpelmann J, Kennedy C, Wysocki J, Batlle D, Burns KD. Podocyte-specific overexpression of human angiotensin-converting enzyme 2 attenuates diabetic nephropathy in mice. Kidney Int 82: 292-303, 2012. doi:10.1038/ki.2012.83.
17. Nakatani S, Ishimura E, Naganuma T, Nakatani A, Ichii M, Fukumoto S, Mori K, Emoto M, Nakatani T, Inaba M. Poor glycemic control and decreased renal function are associated with increased intrarenal RAS activity in Type 2 diabetes mellitus. Diabetes Res Clin Pract 105: 40-46, 2014. doi:10.1016/j.diabres.2014.04.019.
18. Odutayo A, Cherney D. Cystatin C and acute changes in glomerular filtration rate. Clin Nephrol 78: 64-75, 2012. doi:10.5414/CN107324.
19. Park SE, Kim WJ, Park SW, Park JW, Lee N, Park CY, Youn BS. High urinary ACE2 concentrations are associated with severity of glucose intolerance and microalbuminuria. Eur J Endocrinol 168: 203-210, 2013. doi:10.1530/EJE-12-0782.
20. Perkins BA, Sochett EB, Cherney DZ. Ability of Cystatin C to detect changes in glomerular filtration rate after ACE inhibition in patients with uncomplicated type 1 diabetes. Clin Exp Hypertens 34: 606-611, 2012. doi:10.3109/10641963.2012.681732.
21. Price DA, Porter LE, Gordon M, Fisher ND, De'Oliveira JM, Laffel LM, Passan DR, Williams GH, Hollenberg NK. The paradox of the low-renin state in diabetic nephropathy. J Am Soc Nephrol 10: 2382-2391, 1999.
22. Ramaha A, Célérier J, Patston PA. Characterization of different high molecular weight angiotensinogen forms. Am J Hypertens 16: 478-483, 2003. doi:10.1016/S0895-7061(03)00053-0.
23. Saito T, Urushihara M, Kotani Y, Kagami S, Kobori H. Increased urinary angiotensinogen is precedent to increased urinary albumin in patients with type 1 diabetes. Am J Med Sci 338: 478-480, 2009. doi:10.1097/MAJ.0b013e3181b90c25.
24. Salem ES, Grobe N, Elased KM. Insulin treatment attenuates renal ADAM17 and ACE2 shedding in diabetic Akita mice. Am J Physiol Renal Physiol 306: F629-F639, 2014. doi:10.1152/ajprenal.00516.2013.
25. Satirapoj B, Siritaweesuk N, Supasyndh O. Urinary angiotensinogen as a potential biomarker of diabetic nephropathy. Clin Kidney J 7: 354-360, 2014. doi:10.1093/ckj/sfu059.
26. Shi Y, Lo CS, Padda R, Abdo S, Chenier I, Filep JG, Ingelfinger JR, Zhang SL, Chan JS. Angiotensin-(1-7) prevents systemic hypertension, attenuates oxidative stress and tubulointerstitial fibrosis, and normalizes renal angiotensin-converting enzyme 2 and Mas receptor expression in diabetic mice. Clin Sci (Lond) 128: 649-663, 2015. doi:10.1042/CS20140329.
27. Shiota A, Yamamoto K, Ohishi M, Tatara Y, Ohnishi M, Maekawa Y, Iwamoto Y, Takeda M, Rakugi H. Loss of ACE2 accelerates timedependent glomerular and tubulointerstitial damage in streptozotocininduced diabetic mice. Hypertens Res 33: 298-307, 2010. doi:10.1038/hr.2009.231.
28. Soler MJ, Wysocki J, Batlle D. ACE2 alterations in kidney disease. Nephrol Dial Transplant 28: 2687-2697, 2013. doi:10.1093/ndt/gft320.
29. Soler MJ, Wysocki J, Ye M, Lloveras J, Kanwar Y, Batlle D. ACE2 inhibition worsens glomerular injury in association with increased ACE expression in streptozotocin-induced diabetic mice. Kidney Int 72: 614-623, 2007. doi:10.1038/sj.ki.5002373.
30. Soltysiak J, Skowronska B, Fichna P, Ostalska-Nowicka D, Stankiewicz W, Lewandowska-Stachowiak M, Lipkowska K, Zachwieja J. Urinary angiotensinogen and urinary sodium are associated with blood pressure in normoalbuminuric children with diabetes. Pediatr Nephrol 29: 2373-2378, 2014. doi:10.1007/s00467-014-2861-0.
31. Soro-Paavonen A, Gordin D, Forsblom C, Rosengard-Barlund M, Waden J, Thorn L, Sandholm N, Thomas MC, Groop PH; FinnDiane Study Group. Circulating ACE2 activity is increased in patients with type 1 diabetes and vascular complications. J Hypertens 30: 375-383, 2012. doi:10.1097/HJH.0b013e32834f04b6.
32. Tikellis C, Brown R, Head GA, Cooper ME, Thomas MC. Angiotensin- converting enzyme 2 mediates hyperfiltration associated with diabetes. Am J Physiol Renal Physiol 306: F773-F780, 2014. doi:10.1152/ajprenal.00264.2013.
33. Úri K, Fagyas M, Mányiné Siket I, Kertész A, Csanádi Z, Sándorfi G, Clemens M, Fedor R, Papp Z, Édes I, Tóth A, Lizanecz E. New perspectives in the renin-angiotensin-aldosterone system (RAAS) IV: circulating ACE2 as a biomarker of systolic dysfunction in human hypertension and heart failure. PLoS One 9: e87845, 2014. doi:10.1371/journal.pone.0087845.
34. Wang G, Lai FM, Lai KB, Chow KM, Kwan CH, Li KT, Szeto CC. Urinary mRNA expression of ACE and ACE2 in human type 2 diabetic nephropathy. Diabetologia 51: 1062-1067, 2008. doi:10.1007/s00125-008-0988-x.
35. Wang TT, Wu XH, Zhang SL, Chan JS. Effect of glucose on the expression of the angiotensinogen gene in opossum kidney cells. Kidney Int 53: 312-319, 1998. doi:10.1046/j.1523-1755.1998.00775.x.
36. Whaley-Connell AT, Chowdhury NA, Hayden MR, Stump CS, Habibi J, Wiedmeyer CE, Gallagher PE, Tallant EA, Cooper SA, Link CD, Ferrario C, Sowers JR. Oxidative stress and glomerular filtration barrier injury: role of the renin-angiotensin system in the Ren2 transgenic rat. Am J Physiol Renal Physiol 291: F1308-F1314, 2006. doi:10.1152/ajprenal.00167.2006.
37. Wysocki J, Garcia-Halpin L, Ye M, Maier C, Sowers K, Burns KD, Batlle D. Regulation of urinary ACE2 in diabetic mice. Am J Physiol Renal Physiol 305: F600-F611, 2013. doi:10.1152/ajprenal.00600.2012.
38. Wysocki J, Ortiz-Melo DI, Mattocks NK, Xu K, Prescott J, Evora K, Ye M, Sparks MA, Haque SK, Batlle D, Gurley SB. ACE2 deficiency increases NADPH-mediated oxidative stress in the kidney. Physiol Rep 2: e00264, 2014. doi:10.1002/phy2.264.
39. Xiao F, Hiremath S, Knoll G, Zimpelmann J, Srivaratharajah K, Jadhav D, Fergusson D, Kennedy CR, Burns KD. Increased urinary angiotensin-converting enzyme 2 in renal transplant patients with diabetes. PLoS One 7: e37649, 2012. doi:10.1371/journal.pone.0037649.
40. Xiao F, Zimpelmann J, Agaybi S, Gurley SB, Puente L, Burns KD. Characterization of angiotensin-converting enzyme 2 ectodomain shedding from mouse proximal tubular cells. PLoS One 9: e85958, 2014. doi:10.1371/journal.pone.0085958.
41. Ye M, Wysocki J, Naaz P, Salabat MR, LaPointe MS, Batlle D. Increased ACE 2 and decreased ACE protein in renal tubules from diabetic mice: a renoprotective combination? Hypertension 43: 1120-1125, 2004. doi:10.1161/01.HYP.0000126192.27644.76.
42. Ye M, Wysocki J, William J, Soler MJ, Cokic I, Batlle D. Glomerular localization and expression of Angiotensin-converting enzyme 2 and Angiotensin-converting enzyme: implications for albuminuria in diabetes. J Am Soc Nephrol 17: 3067-3075, 2006. doi:10.1681/ASN.2006050423.